In the BP trial , risk of the primary outcome was lower in the groups intensively treated for glycemia ( hazard ratio [ HR ] 0.67 ; 95 % CI 0.50-0 .91 ) , BP ( HR 0.74 ; 95 % CI 0.55-1 .00 ) , or both ( HR 0.71 ; 95 % CI 0.52-0 .96 ) compared with combined standard BP and glycemia treatment .